Intrinsic Value of S&P & Nasdaq Contact Us

Movano Inc. MOVE NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD

SharesGrow Score
20/100
0/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Movano Inc. (MOVE) — Analyst outlook / Analyst consensus target is. Based on 4 analyst ratings, the consensus is bullish — 2 Buy, 2 Hold.

Analysts estimate Earnings Per Share (EPS) of $-42.90 and revenue of $0.00B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-0.39 vs est $-42.90 (beat +99.1%). 2025: actual $-21.79 vs est $-28.00 (beat +22.2%). Analyst accuracy: 0%.

MOVE Analyst Ratings

Buy
4
Ratings
2 Buy
2 Hold
Based on 4 analysts giving stock ratings to Movano Inc. in the past 3 months
Rating breakdown
Buy
2 50%
Hold
2 50%
50%
Buy
2 analysts
50%
Hold
2 analysts
0%
Sell
0 analysts

EPS Estimates — MOVE

0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual –$0.39 vs Est –$42.90 ▲ 10,900.0% off
2025 Actual –$21.79 vs Est –$28.00 ▲ 28.5% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.

Revenue Estimates — MOVE

0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual $0.001B vs Est $0.002B ▼ 137.1% off
2025 Actual $0.000B vs Est $0.016B ▼ 3,479.7% off
Revenue Trend
Revenue has declined over the period shown. Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message